Physician profile
George Manis
NPI 1144431362
$1,937.09
in general payments reported to CMS, 2019-2025
15 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $217 · 2021: $42.48 · 2022: $845 · 2023: $167 · 2024: $375 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353 · Long Term Medical Supply Or Device Loan: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.71 |
| Long Term Medical Supply Or Device Loan | $324.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $701.84 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medical Device Business Services, INC. | $305.00 | 2022 | |
| Smith+Nephew, INC. | $181.20 | 2019-2024 | Grafix Pl, Collagenase Santyl |
| Medtronic Vascular, INC. | $154.96 | 2020 | |
| Kerecis Limited | $150.00 | 2022 | |
| Misonix INC | $94.96 | 2019 | |
| Cagent Vascular INC | $94.65 | 2025 | Serrantor |
| Abbvie INC. | $84.23 | 2022-2023 | |
| Medtronic, INC. | $41.71 | 2024-2025 | Heli-Fx Endoanchor System, Steerant |
| Biom'Up Sa | $27.43 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.50 | 2023 | |
| W. L. Gore & Associates, INC. | $21.80 | 2025 | Gore Excluder Iliac Branch Endoprosthesis |
| Organogenesis INC. | $21.70 | 2020 | |
| Medline Industries LP | $15.79 | 2023 | |
| Tactile Systems Technology INC | $15.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Manis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.